148 related articles for article (PubMed ID: 19715307)
1. Carbamate-linked lactose: design of clusters and evidence for selectivity to block binding of human lectins to (neo)glycoproteins with increasing degree of branching and to tumor cells.
André S; Specker D; Bovin NV; Lensch M; Kaltner H; Gabius HJ; Wittmann V
Bioconjug Chem; 2009 Sep; 20(9):1716-28. PubMed ID: 19715307
[TBL] [Abstract][Full Text] [Related]
2. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins.
André S; Sansone F; Kaltner H; Casnati A; Kopitz J; Gabius HJ; Ungaro R
Chembiochem; 2008 Jul; 9(10):1649-61. PubMed ID: 18509838
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of bivalent lactosides based on terephthalamide, N,N'-diglucosylterephthalamide, and glycophane scaffolds and assessment of their inhibitory capacity on medically relevant lectins.
Leyden R; Velasco-Torrijos T; André S; Gouin S; Gabius HJ; Murphy PV
J Org Chem; 2009 Dec; 74(23):9010-26. PubMed ID: 19899775
[TBL] [Abstract][Full Text] [Related]
4. Lectin-based drug design: combined strategy to identify lead compounds using STD NMR spectroscopy, solid-phase assays and cell binding for a plant toxin model.
Ribeiro JP; André S; Cañada FJ; Gabius HJ; Butera AP; Alves RJ; Jiménez-Barbero J
ChemMedChem; 2010 Mar; 5(3):415-9, 314. PubMed ID: 20094999
[TBL] [Abstract][Full Text] [Related]
5. Persubstituted cyclodextrin-based glycoclusters as inhibitors of protein-carbohydrate recognition using purified plant and mammalian lectins and wild-type and lectin-gene-transfected tumor cells as targets.
André S; Kaltner H; Furuike T; Nishimura S; Gabius HJ
Bioconjug Chem; 2004; 15(1):87-98. PubMed ID: 14733587
[TBL] [Abstract][Full Text] [Related]
6. Wedgelike glycodendrimers as inhibitors of binding of mammalian galectins to glycoproteins, lactose maxiclusters, and cell surface glycoconjugates.
André S; Pieters RJ; Vrasidas I; Kaltner H; Kuwabara I; Liu FT; Liskamp RM; Gabius HJ
Chembiochem; 2001 Nov; 2(11):822-30. PubMed ID: 11948868
[TBL] [Abstract][Full Text] [Related]
7. Bi- to tetravalent glycoclusters: synthesis, structure-activity profiles as lectin inhibitors and impact of combining both valency and headgroup tailoring on selectivity.
Wang GN; André S; Gabius HJ; Murphy PV
Org Biomol Chem; 2012 Sep; 10(34):6893-907. PubMed ID: 22842468
[TBL] [Abstract][Full Text] [Related]
8. Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: a case study on galectins-1 and -3 and the impact of assay setting.
Rapoport EM; André S; Kurmyshkina OV; Pochechueva TV; Severov VV; Pazynina GV; Gabius HJ; Bovin NV
Glycobiology; 2008 Apr; 18(4):315-24. PubMed ID: 18256179
[TBL] [Abstract][Full Text] [Related]
9. Cyclic neoglycodecapeptides: how to increase their inhibitory activity and selectivity on lectin/toxin binding to a glycoprotein and cells.
André S; Renaudet O; Bossu I; Dumy P; Gabius HJ
J Pept Sci; 2011 Jun; 17(6):427-37. PubMed ID: 21294229
[TBL] [Abstract][Full Text] [Related]
10. Glycocluster design for improved avidity and selectivity in blocking human lectin/plant toxin binding to glycoproteins and cells.
André S; Lahmann M; Gabius HJ; Oscarson S
Mol Pharm; 2010 Dec; 7(6):2270-9. PubMed ID: 21028902
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory potential of chemical substitutions at bioinspired sites of β-D-galactopyranose on neoglycoprotein/cell surface binding of two classes of medically relevant lectins.
Giguère D; André S; Bonin MA; Bellefleur MA; Provencal A; Cloutier P; Pucci B; Roy R; Gabius HJ
Bioorg Med Chem; 2011 May; 19(10):3280-7. PubMed ID: 21524586
[TBL] [Abstract][Full Text] [Related]
12. First demonstration of differential inhibition of lectin binding by synthetic tri- and tetravalent glycoclusters from cross-coupling of rigidified 2-propynyl lactoside.
André S; Liu B; Gabius HJ; Roy R
Org Biomol Chem; 2003 Nov; 1(22):3909-16. PubMed ID: 14664382
[TBL] [Abstract][Full Text] [Related]
13. Lectin-mediated drug targeting: selection of valency, sugar type (Gal/Lac), and spacer length for cluster glycosides as parameters to distinguish ligand binding to C-type asialoglycoprotein receptors and galectins.
André S; Frisch B; Kaltner H; Desouza DL; Schuber F; Gabius HJ
Pharm Res; 2000 Aug; 17(8):985-90. PubMed ID: 11028946
[TBL] [Abstract][Full Text] [Related]
14. Assessing the inhibitory potency of galectin ligands identified from combinatorial (glyco)peptide libraries using surface plasmon resonance spectroscopy.
Maljaars CE; André S; Halkes KM; Gabius HJ; Kamerling JP
Anal Biochem; 2008 Jul; 378(2):190-6. PubMed ID: 18471425
[TBL] [Abstract][Full Text] [Related]
15. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.
Patsos G; André S; Roeckel N; Gromes R; Gebert J; Kopitz J; Gabius HJ
Glycobiology; 2009 Jul; 19(7):726-34. PubMed ID: 19293232
[TBL] [Abstract][Full Text] [Related]
16. Bivalent O-glycoside mimetics with S/disulfide/Se substitutions and aromatic core: Synthesis, molecular modeling and inhibitory activity on biomedically relevant lectins in assays of increasing physiological relevance.
Kaltner H; Szabó T; Fehér K; André S; Balla S; Manning JC; Szilágyi L; Gabius HJ
Bioorg Med Chem; 2017 Jun; 25(12):3158-3170. PubMed ID: 28483453
[TBL] [Abstract][Full Text] [Related]
17. Glycosyldisulfides from dynamic combinatorial libraries as O-glycoside mimetics for plant and endogenous lectins: their reactivities in solid-phase and cell assays and conformational analysis by molecular dynamics simulations.
André S; Pei Z; Siebert HC; Ramström O; Gabius HJ
Bioorg Med Chem; 2006 Sep; 14(18):6314-26. PubMed ID: 16782346
[TBL] [Abstract][Full Text] [Related]
18. The emerging functionality of endogenous lectins: A primer to the concept and a case study on galectins including medical implications.
Gabius HJ; Wu AM
Chang Gung Med J; 2006; 29(1):37-62. PubMed ID: 16642727
[TBL] [Abstract][Full Text] [Related]
19. Activity-structure correlations in divergent lectin evolution: fine specificity of chicken galectin CG-14 and computational analysis of flexible ligand docking for CG-14 and the closely related CG-16.
Wu AM; Singh T; Liu JH; Krzeminski M; Russwurm R; Siebert HC; Bonvin AM; André S; Gabius HJ
Glycobiology; 2007 Feb; 17(2):165-84. PubMed ID: 17060369
[TBL] [Abstract][Full Text] [Related]
20. Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3.
Böcker S; Laaf D; Elling L
Biomolecules; 2015 Jul; 5(3):1671-96. PubMed ID: 26213980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
